4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Azeem Alam, Ka Chun Suen, Daqing Ma. Acute-on-chronic liver failure: recent update[J]. The Journal of Biomedical Research, 2017, 31(4): 283-300. DOI: 10.7555/JBR.30.20160060
Citation: Azeem Alam, Ka Chun Suen, Daqing Ma. Acute-on-chronic liver failure: recent update[J]. The Journal of Biomedical Research, 2017, 31(4): 283-300. DOI: 10.7555/JBR.30.20160060

Acute-on-chronic liver failure: recent update

More Information
  • Received Date: May 15, 2016
  • Revised Date: June 15, 2016
  • Acute on chronic liver failure (ACLF) was first described in 1995 as a clinical syndrome distinct to classic acute decompensation. Characterized by complications of decompensation, ACLF occurs on a background of chronic liver dysfunction and is associated with high rates of organ failure and significant short-term mortality estimated between 45% and 90%. Despite the clinical relevance of the condition, it still remains largely undefined with continued disagreement regarding its precise etiological factors, clinical course, prognostic criteria and management pathways. It is concerning that, despite our relative lack of understanding of the condition, the burden of ACLF among cirrhotic patients remains significant with an estimated prevalence of 30.9%. This paper highlights our current understanding of ACLF, including its etiology, diagnostic and prognostic criteria and pathophysiology. It is evident that further refinement of the ACLF classification system is required in order to detect high-risk patients and improve short-term mortality rates. The field of metabolomics certainly warrants investigation to enhance diagnostic and prognostic parameters, while the use of granulocyte-colony stimulating factor is a promising future therapeutic intervention for patients with ACLF.
  • Related Articles

    [1]Chunming Tang, Yanling Wang, Min Wu, Zhiji Wang, Yupeng Zhou, Ya Lin, Yijun Wang, Huae Xu. Cancer cell membrane-camouflaged biomimetic nanoparticles for enhancing chemo-radiation therapy efficacy in glioma[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240100
    [2]Tiwari-Heckler Shilpa, Jiang Z. Gordon, Popov Yury, J. Mukamal Kenneth. Daily high-dose aspirin does not lower APRI in the Aspirin-Myocardial Infarction Study[J]. The Journal of Biomedical Research, 2020, 34(2): 139-142. DOI: 10.7555/JBR.33.20190041
    [3]Huan Liu, Shijiang Zhang, Yongfeng Shao, Xiaohu Lu, Weidong Gu, Buqing Ni, Qun Gu, Junjie Du. Biomechanical characterization of a novel ring connector for sutureless aortic anastomosis[J]. The Journal of Biomedical Research, 2018, 32(6): 454-460. DOI: 10.7555/JBR.31.20170011
    [4]Minbo Zang, Qiao Zhou, Yunfei Zhu, Mingxi Liu, Zuomin Zhou. Effects of chemotherapeutic agent bendamustine for nonhodgkin lymphoma on spermatogenesis in mice[J]. The Journal of Biomedical Research, 2018, 32(6): 442-453. DOI: 10.7555/JBR.31.20170023
    [5]Huanqiang Wang, Congying Yang, Siyuan Wang, Tian Wang, Jingling Han, Kai Wei, Fucun Liu, Jida Xu, Xianzhen Peng, Jianming Wang. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer[J]. The Journal of Biomedical Research, 2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
    [6]Fengzhen Wang, Mingwan Zhang, Dongsheng Zhang, Yuan Huang, Li Chen, Sunmin Jiang, Kun Shi, Rui Li. Preparation, optimization, and characterization of chitosancoated solid lipid nanoparticles for ocular drug delivery[J]. The Journal of Biomedical Research, 2018, 32(6): 411-423. DOI: 10.7555/JBR.32.20160170
    [7]Christopher J. Danford, Zemin Yao, Z. Gordon Jiang. Non-alcoholic fatty liver disease: a narrative review of genetics[J]. The Journal of Biomedical Research, 2018, 32(6): 389-400. DOI: 10.7555/JBR.32.20180045
    [8]Wenping Xu, Sheng Zeng, Min Li, Zhiwen Fan, Bisheng Zhou. Aggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription[J]. The Journal of Biomedical Research, 2017, 31(5): 428-436. DOI: 10.7555/JBR.30.20160046
    [9]Qin Wei, Yeping Bian, Fuchao Yu, Qiang Zhang, Guanghao Zhang, Yang Li, Songsong Song, Xiaomei Ren, Jiayi Tong. Chronic intermittent hypoxia induces cardiac inflammation and dysfunction in a rat obstructive sleep apnea model[J]. The Journal of Biomedical Research, 2016, 30(6): 490-495. DOI: 10.7555/JBR.30.20160110
    [10]Sundeep?S.?Tumber, Hong?Liu. Epidural abscess after multiple lumbar punctures for labour epidural catheter placement[J]. The Journal of Biomedical Research, 2010, 24(4): 332-335. DOI: 10.1016/S1674-8301(10)60046-2
  • Cited by

    Periodical cited type(14)

    1. Stojic J, Kukla M, Grgurevic I. The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status. Diagnostics (Basel), 2023, 13(18): 2960. DOI:10.3390/diagnostics13182960
    2. Kalsi RS, Ostrowska A, Olson A, et al. A non-human primate model of acute liver failure suitable for testing liver support systems. Front Med (Lausanne), 2022, 9: 964448. DOI:10.3389/fmed.2022.964448
    3. Zhang P, Li H, Zhou C, et al. Single-Cell RNA Transcriptomics Reveals the State of Hepatic Lymphatic Endothelial Cells in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. J Clin Med, 2022, 11(10): 2910. DOI:10.3390/jcm11102910
    4. Zhao J, Liu L, Xin L, et al. The Protective Effects of a Modified Xiaohua Funing Decoction against Acute Liver Failure in Mice Induced by D-Gal and LPS. Evid Based Complement Alternat Med, 2022, 2022: 6611563. DOI:10.1155/2022/6611563
    5. Arya P, Kumar U, Sharma S, et al. Targeted NMR-based serum metabolic profiling of serine, glycine and methionine in acute-on-chronic liver failure patients: Possible insights into mitochondrial dysfunction. Anal Sci Adv, 2021, 2(11-12): 536-545. DOI:10.1002/ansa.202000167
    6. Lu Y, Wang G, Li C. Expression of peripheral monocytic programmed death ligand-1 in severe sepsis combined with HBV-related cirrhosis. A pilot observational study. Cent Eur J Immunol, 2021, 46(2): 217-224. DOI:10.5114/ceji.2021.108179
    7. Guo J, Zhang Z, Zhu J. Preparation of MED1(transcription mediator subunit) gene nanocarrier and its mechanism of action on liver cell regeneration in chronic acute liver failure. Bioengineered, 2021, 12(1): 7600-7615. DOI:10.1080/21655979.2021.1981756
    8. Shang J, Wang M, Wen Q, et al. A novel prognostic model to predict outcome of artificial liver support system treatment. Sci Rep, 2021, 11(1): 7510. DOI:10.1038/s41598-021-87055-8
    9. Li Q, Wang J, Lu M, et al. Acute-on-Chronic Liver Failure From Chronic-Hepatitis-B, Who Is the Behind Scenes. Front Microbiol, 2020, 11: 583423. DOI:10.3389/fmicb.2020.583423
    10. Wang S, Xiong H, Luo C, et al. Acute-on-Chronic Liver Failure in Pregnant Patients with Chronic Hepatitis B: A Retrospective Observational Case Series Study. Gastroenterol Res Pract, 2020, 2020: 9831687. DOI:10.1155/2020/9831687
    11. Seo BR, Chen X, Ling L, et al. Collagen microarchitecture mechanically controls myofibroblast differentiation. Proc Natl Acad Sci U S A, 2020, 117(21): 11387-11398. DOI:10.1073/pnas.1919394117
    12. Yang W, Hao Y, Hou W, et al. Jieduan-Niwan Formula Reduces Liver Apoptosis in a Rat Model of Acute-on-Chronic Liver Failure by Regulating the E2F1-Mediated Intrinsic Apoptosis Pathway. Evid Based Complement Alternat Med, 2019, 2019: 8108503. DOI:10.1155/2019/8108503
    13. Xu X, Bai Z, Zhao Q, et al. Successful Pharmacotherapy for Multiple Acute Decompensation Events in a Cirrhotic Patient with Acute-on-chronic Liver Failure: A Case Report. J Transl Int Med, 2018, 6(4): 189-193. DOI:10.2478/jtim-2018-0035
    14. Zhang T, Sun K, Wang Y, et al. Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure. Eur J Gastroenterol Hepatol, 2018, 30(2): 130-135. DOI:10.1097/MEG.0000000000001026

    Other cited types(0)

Catalog

    Article Metrics

    Article views (3842) PDF downloads (385) Cited by(14)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return